企業プロフィール
Kezar Life Sciences 株価・ニュース・カタリスト
- ティッカー:
- KZR
- 取引所:
- NASDAQ
- セクター:
- Life Science Tools
- 所在地:
- United States
株価パフォーマンス
7.29 USD (-0.95%)
終値
最終更新: 2026年5月8日
53.9M USD
時価総額
株価変動の要因
Current closing-price context is not available for KZR.
企業概要
事業概要
Kezar Life Sciences is a biotechnology company focused on immune pathways in autoimmune disease and oncology. Its strategy has centered on selective small-molecule biology and translational proof.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Kezar sits in specialty biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, target validation, and the possibility of building a differentiated immune-modulation platform.
バイオ業界での位置付け
Kezar is a catalyst-sensitive immunology name whose stock is driven by proof-of-concept and strategic updates.
今後のカタリスト
- Kezar’s catalysts are zetomipzomib and the remaining immunology pipeline, where the next update matters because the market needs a clearer read on what still has value. The company is in a reset phase, so strategic clarity matters as much as data.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。